Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

HRTX Quote, Trading Chart, Heron Therapeutics Inc.


home / stock / hrtx / hrtx quote

$17.29 Last:

2.01% Change Percent:

$17.25 Open:

$17.29 Previous Close:

$17.55 High:

$16.45 Low:

733,755 Volume:

03/05/2021 03:15:31 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-0517.2517.2917.5516.45733,755
2021-03-0417.216.9517.5516.511,128,405
2021-03-0317.5717.2817.8417.08834,156
2021-03-0218.0117.6818.2117.66666,868
2021-03-0118.4118.0918.61517.88838,665
2021-02-2618.0418.0818.9317.87957,672
2021-02-2519.1618.0520.4517.932,207,938
2021-02-2418.0419.3119.5717.57947,182
2021-02-2318.1817.8618.488317.57667,302
2021-02-2218.8118.41918.39540,810
2021-02-1918.21919.4318.2781,985
2021-02-1818.4718.1818.7718.13576,274
2021-02-1718.54518.4918.81518.16744,820
2021-02-1618.8718.3118.8717.98670,716
2021-02-1518.4818.3419.0318.22592,191
2021-02-1218.4818.3419.0318.22591,964
2021-02-1119.3818.5119.518.4583,420
2021-02-1019.7619.3420.0319.04493,260
2021-02-0919.6519.719.8919.21618,672
2021-02-0819.5119.5620.1119.381,111,657
Stock Information

Heron Therapeutics Inc. Company Name:

HRTX Stock Symbol:

NASDAQ Market:

Heron Therapeutics Inc. Website:

MENU
HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT HRTX NEWS
  • HRTX - Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

    Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates PR Newswire SAN DIEGO , Feb. 24, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotec...

  • HRTX - Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery

    Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery - 77% of Bunionectomy Patients Receiving HTX-011 Required No Opioids to Manage Their Postoperative Pain Through 72 Hours After Surgery and Cont...

  • HRTX - Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program

    Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program - Preliminary Full-Year 2020 Net Product Sales for CINV Franchise of Approximately $88.3 Million, versus Guidance of $85 Million - - Full-Year 2021 Net Product...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News